Study on the clinical and etiological profile of hepatocellular carcinoma in a tertiary care centre in south India: a prospective observational study
DOI:
https://doi.org/10.18203/2349-3933.ijam20223397Keywords:
Hepatocellular, Carcinoma, Hepatitis B virus, AlcoholAbstract
Background: Hepatocellular carcinoma (HCC) is the most common primary malignant tumour of the liver occurring in patients with underlying chronic liver disease with high morbidity and mortality with various clinical presentations. This study was conducted to analyse the clinical and etiological profiles of HCC patients in tertiary care liver transplant centre.
Methods: This prospective cross-sectional study was conducted in the department of medical gastroenterology, government Stanley medical college, for one year, with a sample size of 75 patients. Clinical details, demography, laboratory parameters and imaging findings are entered in pre-structured proforma.
Results: Among 75 patients, 69 were males (92%). The mean age of patients was 45.5±10 years. Abdominal pain in 56 (80%) and abdominal distension in 31 patients (44.2%%) was the most common symptom, with underlying cirrhosis in a majority (70.6%). The etiologies include hepatitis B in 25 (33.3%), ethanol in 20 (26.6%), hepatitis C in 8 (10.6%), NAFLD in 8 (10.6%) and cryptogenic in 11 (14.6%) patients. AFP levels >400 ng/ml were observed in 37 cases (49.3%) with a mean value of 6129 ng/ml with normal in 12 (16%) cases. On imaging, multifocal lesions were seen in 24(32%) patients and vascular invasion in 30 (40%) patients. Most of the patients belong to BCLC stage C (54.6%), followed by stage B (30.6%) and stage A (12%) and two patients (2.6%) in stage D. Patients were managed according to institutional protocol with either hepatectomy, TACE, systemic chemotherapy or combination of these modalities.
Conclusions: In our study, HBV (33%) and alcohol (27%) were the most common etiologies, with the majority having underlying cirrhosis.
References
Balogh J, Victor D 3rd, Asham EH, Burroughs SG, Boktour M, Saharia A et al. Hepatocellular carcinoma: a review. J Hepatocell Carcinoma. 2016;3:41-53.
Acharya SK. Epidemiology of hepatocellular carcinoma in India. J Clin Exp Hepatol. 2014;4(3):S27-33.
Kar P. Risk factors for hepatocellular carcinoma in India. J Clin Exp Hepatol. 2014;4(3):S34-42.
Ashtari S, Pourhoseingholi MA, Sharifian A, Zali MR. Hepatocellular carcinoma in Asia: Prevention strategy and planning. World J Hepatol. 2015;7(12):1708-17.
Sun VC, Sarna L. Symptom management in hepatocellular carcinoma. Clin J Oncol Nurs. 2008;12(5):759-66.
Bialecki ES, Di Bisceglie AM. Diagnosis of hepatocellular carcinoma. HPB (Oxford). 2005;7(1):26-34.
Bosch FX. Global epidemiology of hepatocellular carcinoma. In Okuda K, Tabor E, eds. Liver cancer. New York, Churchill Livingstone. 1997;13-27.
Kumar R, Saraswat MK, Sharma BC, Sakhuja P, Sarin SK. Characteristics of hepatocellular carcinoma in India: a retrospective analysis of 191 cases. Q J Med. 2008;101:479-85.
Pyrsopoulos N, Reddy RK. Hepatocellular carcinoma in Asia. In: sarin SK, Okuda K, (cds). Hepatitis B and C. Carrier to cancer. India: Elsevier. 2002;268-71.
Shiratori Y, Shiina S, Imamura M. Characteristic difference of hepatocellular carcinoma between hepatitis B- and C-viral infection in Japan. Hepatology. 1995;22:1027-33.
Sarin SK, Thakur V, Guptan RC. Profile of hepatocellular carcinoma in India: an insight into the possible etiologic associations. J Gastroenterol Hepatol. 2001;16:666-73.
Kapoor S, Gupta SK, Dhiman RK. Hepatocellular carcinoma at PGI Chandigarh. Indian J Gastroenterol. 1999;18:s3624.
Tandon BN, Acharya SK, Tandon A. Epidemiology of Hepatitis B virus infection in India. Gut. 1996;38:856-9.
Sherman M. Alpha-fetoprotein: an obituary. J Hepatol. 2001;34:603-5.
Tangkijvanich P, Anukulkamusol N, Suwangool P, Lert-maharit S, Hanvivatvong O, Kullavanijaya P et al. Clinical characteristics and prognosis of hepatocellular carcinoma: an analysis based on serum alpha-fetoprotein levels. J Clin Gastroenterol. 2000;31:302-8.
Butt AK, Khan AA, Alam A. Hepatocellular carcinoma: analysis of 76 cases. J Pak Med Assoc. 1998;48:197-201.
Paul SB, Gulati MS, Madan K. incidence of hepatocellular carcinoma among Indian patients with liver cirrhosis: an experience from a tertiary care centre in northern India. Indian J Gastroenterol. 2007;26:274-6.
